These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2777203)

  • 1. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss.
    Mitchison HC; Bassendine MF; Malcolm AJ; Watson AJ; Record CO; James OF
    Hepatology; 1989 Oct; 10(4):420-9. PubMed ID: 2777203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results.
    Mitchison HC; Palmer JM; Bassendine MF; Watson AJ; Record CO; James OF
    J Hepatol; 1992 Jul; 15(3):336-44. PubMed ID: 1447500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.
    Wolfhagen FH; van Buuren HR; den Ouden JW; Hop WC; van Leeuwen JP; Schalm SW; Pols HA
    J Hepatol; 1997 Feb; 26(2):325-30. PubMed ID: 9059953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.
    Wolfhagen FH; van Hoogstraten HJ; van Buuren HR; van Berge-Henegouwen GP; ten Kate FJ; Hop WC; van der Hoek EW; Kerbert MJ; van Lijf HH; den Ouden JW; Smit AM; de Vries RA; van Zanten RA; Schalm SW
    J Hepatol; 1998 Nov; 29(5):736-42. PubMed ID: 9833911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis.
    Leuschner M; Güldütuna S; You T; Hübner K; Bhatti S; Leuschner U
    J Hepatol; 1996 Jul; 25(1):49-57. PubMed ID: 8836901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of colchicine therapy in primary biliary cirrhosis.
    Bodenheimer H; Schaffner F; Pezzullo J
    Gastroenterology; 1988 Jul; 95(1):124-9. PubMed ID: 3286360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study.
    McCormick PA; Scott F; Epstein O; Burroughs AK; Scheuer PJ; McIntyre N
    J Hepatol; 1994 Oct; 21(4):496-9. PubMed ID: 7814794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial.
    Leuschner M; Maier KP; Schlichting J; Strahl S; Herrmann G; Dahm HH; Ackermann H; Happ J; Leuschner U
    Gastroenterology; 1999 Oct; 117(4):918-25. PubMed ID: 10500075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Balkau B; Eschwège E; Poupon R
    N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone for primary biliary cirrhosis--good news, bad news.
    Combes B
    Hepatology; 1989 Oct; 10(4):511-3. PubMed ID: 2777211
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective trial of colchicine for primary biliary cirrhosis.
    Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
    N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
    Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J
    Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis.
    Minuk GY; Bohme CE; Burgess E; Hershfield NB; Kelly JK; Shaffer EA; Sutherland LR; Van Rosendaal G
    Gastroenterology; 1988 Nov; 95(5):1356-63. PubMed ID: 3169499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Combes B; Carithers RL; Maddrey WC; Lin D; McDonald MF; Wheeler DE; Eigenbrodt EH; Muñoz SJ; Rubin R; Garcia-Tsao G
    Hepatology; 1995 Sep; 22(3):759-66. PubMed ID: 7657280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.
    Leuschner U; Fischer H; Kurtz W; Güldütuna S; Hübner K; Hellstern A; Gatzen M; Leuschner M
    Gastroenterology; 1989 Nov; 97(5):1268-74. PubMed ID: 2551765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic bone disease in primary biliary cirrhosis at presentation.
    Mitchison HC; Malcolm AJ; Bassendine MF; James OF
    Gastroenterology; 1988 Feb; 94(2):463-70. PubMed ID: 3335317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
    Poupon RE; Eschwège E; Poupon R
    J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of penicillamine in advanced primary biliary cirrhosis.
    Dickson ER; Fleming TR; Wiesner RH; Baldus WP; Fleming CR; Ludwig J; McCall JT
    N Engl J Med; 1985 Apr; 312(16):1011-5. PubMed ID: 3885033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
    Nevens F; Andreone P; Mazzella G; Strasser SI; Bowlus C; Invernizzi P; Drenth JP; Pockros PJ; Regula J; Beuers U; Trauner M; Jones DE; Floreani A; Hohenester S; Luketic V; Shiffman M; van Erpecum KJ; Vargas V; Vincent C; Hirschfield GM; Shah H; Hansen B; Lindor KD; Marschall HU; Kowdley KV; Hooshmand-Rad R; Marmon T; Sheeron S; Pencek R; MacConell L; Pruzanski M; Shapiro D;
    N Engl J Med; 2016 Aug; 375(7):631-43. PubMed ID: 27532829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.